Publications:

Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation.

Frontiers In Oncology

Rao, Chuangzhou C; Nie, Liangqin L; Wu, Xiaokang X; Miao, Xiaobo X; Chen, Ting T; Chen, Liuxi L; Zhang, Dongqing D; Lin, Quan Q

Publication Date: 2022

Variant appearance in text: ALK: C1156S

PubMed Link: 36203454

Variant Present in the following documents:

• Main text
• fonc-12-915502.pdf

View BVdb publication page

[Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer

Wang, Shasha S; Shi, Yuankai Y; Han, Xiaohong X

Publication Date: 2020-11-20

Variant appearance in text: ALK: C1156S

PubMed Link: 33203201

Variant Present in the following documents:

• Main text

View BVdb publication page

Results of Liquid Biopsy Studies by Next Generation Sequencing in Patients with Advanced Stage Non-small Cell Lung Cancer: Single Center Experience from Turkey.

Balkan Journal Of Medical Genetics : Bjmg

Buyuksimsek, M M; Togun, M M; Oguz, Kara I KI; Bisgin, A A; Boga, I I; Tohumcuoglu, M M; Ogul, A A; Evren, Yetisir A YA; Sahin, B B; Erdem, Sumbul H SH; Mirili, C C

Publication Date: 2019-12

Variant appearance in text: ALK: C1156S

PubMed Link: 31942412

Variant Present in the following documents:

• Main text
• bjmg-22-017.pdf

View BVdb publication page

Transfer of Extracellular Vesicle-Associated-RNAs Induces Drug Resistance in ALK-Translocated Lung Adenocarcinoma.

Cancers

Kwok, Hoi-Hin HH; Ning, Ziyu Z; Chong, Peony Wing-Chi PW; Wan, Thomas Shek-Kong TS; Ng, Margaret Heung-Ling MH; Ho, Gloria Y F GYF; Ip, Mary Sau-Man MS; Lam, David Chi-Leung DC

Publication Date: 2019-01-17

Variant appearance in text: ALK: C1156S

PubMed Link: 30658414

Variant Present in the following documents:

• Main text
• cancers-11-00104.pdf

View BVdb publication page